Preclinical development of HIvax: Human survivin highly immunogenic vaccines

Our previous work involved the development of a recombinant fowlpox virus encoding survivin (FP-surv) vaccine that was evaluated for efficacy in mesothelioma mouse models. Results showed that FP-surv vaccination generated significant immune responses, which led to delayed tumor growth and improved a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Hum Vaccin Immunother
मुख्य लेखकों: Hoffmann, Peter R, Panigada, Maddalena, Soprana, Elisa, Terry, Frances, Bandar, Ivo Sah, Napolitano, Andrea, Rose, Aaron H, Hoffmann, Fukun W, Ndhlovu, Lishomwa C, Belcaid, Mahdi, Moise, Lenny, De Groot, Anne S, Carbone, Michele, Gaudino, Giovanni, Matsui, Takashi, Siccardi, Antonio, Bertino, Pietro
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis 2015
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514257/
https://ncbi.nlm.nih.gov/pubmed/26042612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1050572
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन